Corvallis, OR, United States of America

Daniel D Rockey

This inventor holds 1 USPTO granted patent. Top assignee: Oregon State University. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel D. Rockey

Introduction

Daniel D. Rockey is an accomplished inventor based in Corvallis, Oregon. He has made significant contributions to the field of microbiology, particularly in the study of Chlamydia. His work focuses on infection-specific proteins that have the potential to lead to advancements in vaccine development.

Latest Patents

Daniel D. Rockey holds a patent for "Chlamydia proteins and their uses." This invention highlights the discovery that certain Chlamydia proteins are infection-specific and primarily associated with the vegetative Reticulate Body form of Chlamydia. The patent includes a vaccine directed against this form, comprising one or more infection-specific proteins. Additionally, it outlines methods for using the vaccine, producing it, and detecting infection-specific antibodies and antigens in biological specimens. The invention also encompasses therapeutic agents aimed at treating chlamydial infections.

Career Highlights

Rockey is affiliated with Oregon State University, where he conducts research and contributes to the academic community. His work has garnered attention for its potential impact on public health, particularly in combating Chlamydia infections.

Collaborations

Daniel D. Rockey collaborates with John P. Bannantine, a fellow researcher in the field. Their partnership enhances the research efforts and broadens the scope of their investigations into Chlamydia.

Conclusion

Daniel D. Rockey's innovative work in the field of microbiology, particularly regarding Chlamydia proteins, showcases his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in vaccine development and infection treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…